SARS-CoV-2 (COVID-19) Beta Variant ( B.1.351, SA) Spike RBD Recombinant Protein Cat. No.: 21-825

Availability: In stock

$0.00

 Price Options

$0.00
psi-iconSpecifications
SPECIES:SARS-CoV-2 (COVID-19, 2019-nCoV) Spike RBD Protein
SOURCE SPECIES:HEK293 cells
SEQUENCE:sequence (aa 319 – 537), N501Y
C-terminal His tag
FUSION TAG:C-terminal His tag
TESTED APPLICATIONS:ELISA
APPLICATIONS:This recombinant protein can be used for ELISA assays, Ligand binding assays (e.g. SPR), Biochemical and biophysical analyses. For research use only.
BIOLOGICAL ACTIVITY: not determined
psi-iconProperties
PURITY:>98% as determined by SDS-PAGE, see Fig. 1 A and B. PureCube Indigo Agarose.
PREDICTED MOLECULAR WEIGHT:225 amino acids (including His tag); 25506 Da
PHYSICAL STATE:Liquid
BUFFER:20 mM Hepes pH 7.5; 150 mM NaCl
CONCENTRATION:batch dependent
STORAGE CONDITIONS:–80˚C. Avoid freeze-thaw cycles
psi-iconAdditional Info
ALTERNATE NAMES:SARS-CoV-2 (COVID-19) Spike RBD Recombinnat Protein: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Surface Glycoprotein, Spike protein
OFFICIAL SYMBOL:S
GENE ID:43740568
psi-iconBackground and References
BACKGROUND:All viruses undergo fast mutations and adept quickly to the countermeasures that the immune systems creates against them. SARS-CoV-2 of the COVID-19 pandemic is no exception here. During the pandemic multiple mutant strains arose. To help the science combat these mutants ProSci offers the RB-Domains of these mutant SPIKE proteins. That is the full Receptor-Binding Domain of the SPIKE surface protein SARS-CoV-2 of the mutant strain B.1.351, also commonly known as the "SA / South Africa mutant".

FOR RESEARCH USE ONLY.

For additional information, visit ProSci's Terms & Conditions Page.